Cancer epigenomics: DNA methylomes and histone-modification maps

被引：1545

作者：

Esteller, Manel ^{[1
]}

机构：

[1] CNIO, Canc Energet Lab, Spanish Natl Canc Ctr, Madrid 28029, Spain

来源：

NATURE REVIEWS GENETICS | 2007年 / 8卷 / 04期

关键词：

D O I：

10.1038/nrg2005

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

An altered pattern of epigenetic modifications is central to many common human diseases, including cancer. Many studies have explored the mosaic patterns of DNA methylation and histone modification in cancer cells on a gene-by-gene basis; among their results has been the seminal finding of transcriptional silencing of tumour-suppressor genes by CpG-island-promoter hypermethylation. However, recent technological advances are now allowing cancer epigenetics to be studied genome-wide-an approach that has already begun to provide both biological insight and new avenues for translational research. It is time to 'upgrade' cancer epigenetics research and put together an ambitious plan to tackle the many unanswered questions in this field using epigenomics approaches.

引用

页码：286 / 298

页数：13

共 104 条

[71]

RAKLAN VK, 2004, PLOS BIOL, V2, pE405

[72] It is time for a Human Epigenome Project [J].

Rauscher, FJ .

CANCER RESEARCH, 2005, 65 (24) :11229-11229

[73] Co-evolution of X-chromosome inactivation and imprinting in mammals [J].

Reik, W ;

Lewis, A .

NATURE REVIEWS GENETICS, 2005, 6 (05) :403-410

[74] Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation [J].

Richon, VM ;

Sandhoff, TW ;

Rifkind, RA ;

Marks, PA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10014-10019

[75] A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition [J].

Ropero, S ;

Fraga, MF ;

Ballestar, E ;

Hamelin, R ;

Yamamoto, H ;

Boix-Chornet, M ;

Caballero, R ;

Alaminos, M ;

Setien, F ;

Paz, MF ;

Herranz, M ;

Palacios, J ;

Arango, D ;

Orntoft, TF ;

Aaltonen, LA ;

Schwartz, S ;

Esteller, M .

NATURE GENETICS, 2006, 38 (05) :566-569

[76] Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells [J].

Saito, Yoshimasa ;

Liang, Gangning ;

Egger, Gerda ;

Friedman, Jeffrey M. ;

Chuang, Jody C. ;

Coetzee, Gerhard A. ;

Jones, Peter A. .

CANCER CELL, 2006, 9 (06) :435-443

[77] Methylation of histone H4 lysine 20 controls recruitment of Crb2 to sites of DNA damage [J].

Sanders, SL ;

Portoso, M ;

Mata, J ;

Bähler, J ;

Allshire, RC ;

Kouzarides, T .

CELL, 2004, 119 (05) :603-614

[78] Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer [J].

Schlesinger, Yeshayahu ;

Straussman, Ravid ;

Keshet, Ilana ;

Farkash, Shlomit ;

Hecht, Merav ;

Zimmerman, Joseph ;

Eden, Eran ;

Yakhini, Zohar ;

Ben-Shushan, Etti ;

Reubinoff, Benjamin E. ;

Bergman, Yehudit ;

Simon, Itamar ;

Cedar, Howard .

NATURE GENETICS, 2007, 39 (02) :232-236

[79] The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote [J].

Schübeler, D ;

MacAlpine, DM ;

Scalzo, D ;

Wirbelauer, C ;

Kooperberg, C ;

van Leeuwen, F ;

Gottschling, DE ;

O'Neill, LP ;

Turner, BM ;

Delrow, J ;

Bell, SP ;

Groudine, M .

GENES & DEVELOPMENT, 2004, 18 (11) :1263-1271

[80] Global histone modification patterns predict risk of prostate cancer recurrence [J].

Seligson, DB ;

Horvath, S ;

Shi, T ;

Yu, H ;

Tze, S ;

Grunstein, M ;

Kurdistani, SK .

NATURE, 2005, 435 (7046) :1262-1266

← 2 3 4 5 6 7 8 9 10 11 →